FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

4074401000001100: Report all adverse reactions to the CSM (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2004. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
10072501000001113 Report all adverse reactions to the CSM en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36829301000001115 Report all adverse reactions to the CSM (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Report all adverse reactions to the CSM Is a CSM warning status messages true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Efavirenz 100mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Rebetol 200mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ribavirin 200mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ribavirin 100mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Tamiflu 12mg/mL oral suspension CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Tamiflu 75mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Vfend 200mg i-v infusion (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Vfend 200mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Vfend 50mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Voriconazole 200mg i-v infusion (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Voriconazole 200mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Voriconazole 50mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Caspofungin MSD 70mg infusion concentrate (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Caspofungin 70mg infusion concentrate (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Caspofungin MSD 50mg infusion concentrate (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Caspofungin 50mg infusion concentrate (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Itraconazole 250mg/25mL infusion concentrate - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sporanox IV 250mg/25mL infusion concentrate CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Indivina 2mg/5mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Testoderm 6mg/24hours transdermal patch CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Lutropin alfa 75iu injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Luveris 75iu injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Alendronic acid 70mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Fosamax Once Weekly 70mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Salcatonin 200iu nasal spray CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Miacalcic 200iu nasal spray CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Choriogonadotropin alfa 250micrograms injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ovitrelle 250micrograms injection (pdr for recon)+solvent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Propecia 1mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Finasteride 1mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Testosterone 6mg/24hours transdermal patch CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Indivina 1mg/5mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Indivina 1mg/2.5mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Bondronat 1mg/mL intravenous infusion conc 2mL ampoule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ibandronic acid 1mg/mL intravenous infusion conc CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Zoledronic acid 4mg i-v infusion (pdr for recon)+diluent - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Zometa 4mg i-v infusion (pdr for recon)+diluent CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
NovoNorm 1mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
NovoNorm 0.5mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Repaglinide 2mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Repaglinide 1mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Repaglinide 0.5mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Uprima 2mg sublingual tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Uprima 3mg sublingual tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Apomorphine hydrochloride 3mg sublingual tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Apomorphine hydrochloride 2mg sublingual tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Tegafur+uracil 100mg/224mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Uftoral 100mg/224mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Capecitabine 150mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Capecitabine 500mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Xeloda 500mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Xeloda 150mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Fludarabine phosphate 10mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Fludara 10mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Paclitaxel 300mg/50mL infusion concentrate - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Taxol 300mg/50mL infusion concentrate CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Taxol 100.2mg/16.7mL infusion concentrate CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Paclitaxel 100.2mg/16.7mL infusion concentrate - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Paclitaxel 30mg/5mL infusion concentrate - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Taxol 30mg/5mL infusion concentrate CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Topotecan 1mg i-v infusion (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Hycamtin 1mg i-v infusion (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Hycamtin 4mg i-v infusion (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Topotecan 4mg i-v infusion (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Verteporfin 15mg i-v infusion (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Visudyne 15mg i-v infusion (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Temozolomide 250mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Temozolomide 100mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Temozolomide 20mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Temozolomide 5mg capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Temodal 250mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Temodal 100mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Temodal 20mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Temodal 5mg capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Spiriva 18micrograms inhalation capsule CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Spiriva Combopack 18micrograms capsule+HandiHaler inhaler device CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Tiotropium 18micrograms capsule+inhaler device - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Tiotropium 18micrograms inhalation capsule - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Flixotide 50micrograms Evohaler CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Fluticasone propionate 50micrograms CFC-free inhaler - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Flixotide 250micrograms Evohaler CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Flixotide 125micrograms Evohaler CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Fluticasone propionate 250micrograms CFC-free inhaler - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Fluticasone propionate 125micrograms CFC-free inhaler - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Calcitriol 3micrograms/g ointment CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Agalsidase beta 35mg i-v infusion (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Fabrazyme 35mg i-v infusion (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Imiglucerase 200units infusion (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Imiglucerase 400units infusion (pdr for recon) - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Cerezyme 400units infusion (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Cerezyme 200units infusion (pdr for recon) CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ceredase 50units intravenous infusion conc CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ceredase 400units intravenous infusion conc CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Alglucerase 50units/5mL intravenous infusion conc CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Alglucerase 400units/5mL intravenous infusion conc CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Deferiprone 500mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ferriprox 500mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sodium phenylbutyrate 940mg/g granules - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Sodium phenylbutyrate 500mg tablet - product CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ammonaps 940mg/g granules CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier
Ammonaps 500mg tablet CSM recommendation to report adverse reactions False Report all adverse reactions to the CSM Additional relationship Existential restriction modifier

Start Page 2 of 8 Next End

This concept is not in any reference sets

Back to Start